“Prescription of Glucagon-Like Peptide 1 (GLP-1) in the treatment of patients with type 2 diabetes and obesity: a literature review”, Acervo Médico, vol. 11, p. e10289, Jun. 2022, doi: 10.25248/reamed.e10289.2022.